JPWO2019157158A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019157158A5 JPWO2019157158A5 JP2020542611A JP2020542611A JPWO2019157158A5 JP WO2019157158 A5 JPWO2019157158 A5 JP WO2019157158A5 JP 2020542611 A JP2020542611 A JP 2020542611A JP 2020542611 A JP2020542611 A JP 2020542611A JP WO2019157158 A5 JPWO2019157158 A5 JP WO2019157158A5
- Authority
- JP
- Japan
- Prior art keywords
- population
- cell populations
- treg
- populations according
- tcon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024004747A JP7652949B2 (ja) | 2018-02-08 | 2024-01-16 | 同種造血幹細胞移植のための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862628015P | 2018-02-08 | 2018-02-08 | |
| US62/628,015 | 2018-02-08 | ||
| PCT/US2019/017017 WO2019157158A2 (en) | 2018-02-08 | 2019-02-07 | Methods for allogenic hematopoietic stem cell transplantation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024004747A Division JP7652949B2 (ja) | 2018-02-08 | 2024-01-16 | 同種造血幹細胞移植のための方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021512903A JP2021512903A (ja) | 2021-05-20 |
| JPWO2019157158A5 true JPWO2019157158A5 (https=) | 2022-02-15 |
| JP2021512903A5 JP2021512903A5 (https=) | 2022-02-15 |
| JP7422667B2 JP7422667B2 (ja) | 2024-01-26 |
Family
ID=67549051
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542611A Active JP7422667B2 (ja) | 2018-02-08 | 2019-02-07 | 同種造血幹細胞移植のための方法 |
| JP2024004747A Active JP7652949B2 (ja) | 2018-02-08 | 2024-01-16 | 同種造血幹細胞移植のための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024004747A Active JP7652949B2 (ja) | 2018-02-08 | 2024-01-16 | 同種造血幹細胞移植のための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US11952588B2 (https=) |
| EP (2) | EP4529957A3 (https=) |
| JP (2) | JP7422667B2 (https=) |
| CN (1) | CN111971052B (https=) |
| AU (2) | AU2019218792A1 (https=) |
| CA (1) | CA3090175A1 (https=) |
| DK (1) | DK3749334T3 (https=) |
| ES (1) | ES3012854T3 (https=) |
| PL (1) | PL3749334T3 (https=) |
| WO (1) | WO2019157158A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3749334T3 (da) | 2018-02-08 | 2025-02-17 | Univ Leland Stanford Junior | Allogen hæmatopoietisk stamcelletransplantation |
| KR20200130324A (ko) | 2018-02-23 | 2020-11-18 | 에이치 리 모피트 캔서 센터 앤드 리서어치 인스티튜트 아이엔씨 | Cd83-결합 키메라 항원 수용체 |
| JP7701908B2 (ja) * | 2019-08-16 | 2025-07-02 | エイチ リー モフィット キャンサー センター アンド リサーチ インスティテュート インコーポレイテッド | 抗ｃｄ３８キメラ抗原受容体を発現する制御性ｔ細胞 |
| CN117177748A (zh) * | 2020-11-04 | 2023-12-05 | 浩康生物系统公司 | 用于异基因造血干细胞移植的方法 |
| WO2022098926A1 (en) * | 2020-11-04 | 2022-05-12 | Orca Biosystems, Inc. | Methods for allogeneic hematopoietic stem cell transplantation |
| AU2022245339A1 (en) * | 2021-03-25 | 2023-08-31 | Cellenkos, Inc. | Populations of enriched regulatory t cells and methods for producing same |
| EP4426318A4 (en) * | 2021-11-04 | 2025-11-19 | Orca Biosystems Inc | THERAPEUTIC COMPOSITIONS AND TRANSPLANTATION PROCESSES OF ALLOGENEIC HEMATOPOIETIC CELLS |
| AU2023252879A1 (en) * | 2022-04-15 | 2024-11-21 | Orca Biosystems, Inc. | Methods for allogeneic hematopoietic stem cell transplantation |
| EP4709398A2 (en) * | 2023-05-09 | 2026-03-18 | The McLean Hospital Corporation | Intra-striatal co-transplantation of autologous treg and mda cells in parkinson's disease cell therapy |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL107483A0 (en) | 1993-11-03 | 1994-02-27 | Yeda Res & Dev | Bone marrow transplantation |
| US20050163760A1 (en) | 2001-12-06 | 2005-07-28 | Nathalie Cartier-Lacave | Use of cd34+ hematopoietic progenitor cells for the treatment of cns disorders |
| JP4988172B2 (ja) | 2005-06-24 | 2012-08-01 | 株式会社日立製作所 | 固体酸化物形燃料電池発電システム |
| EP1928479B1 (en) | 2005-08-24 | 2016-06-08 | Yeda Research And Development Co., Ltd. | Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance |
| US8632768B2 (en) | 2008-05-30 | 2014-01-21 | University Of Louisville Research Foundation, Inc. | Human facilitating cells |
| US11291686B2 (en) | 2008-05-30 | 2022-04-05 | University Of Louisville Research Foundation, Inc. | Human facilitating cells |
| WO2010022341A1 (en) | 2008-08-21 | 2010-02-25 | The United State Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of enriching and using regulatory t cells |
| JP5756017B2 (ja) | 2008-11-07 | 2015-07-29 | サニーブルック ヘルス サイエンシズ センター | ヒト前駆ｔ細胞 |
| EP2461828B1 (en) | 2009-07-31 | 2017-06-21 | President and Fellows of Harvard College | Programming of cells for tolerogenic therapies |
| EP2378287A1 (en) | 2010-04-15 | 2011-10-19 | TXCell | New method for isolating Tr1 cells |
| MX370404B (es) | 2011-12-22 | 2019-12-11 | Yeda Res & Dev | Uso de una terapia de combinación para inducir un injerto estable y a largo plazo. |
| WO2013130499A1 (en) | 2012-02-29 | 2013-09-06 | University Of Virginia Patent Foundation | Compositions and methods for cxcr4 signaling and umbilical cord blood stem cell engraftment |
| WO2013173076A1 (en) * | 2012-05-04 | 2013-11-21 | University Of Southern California | Methods and compositions for generating and using allogeneic suppressor cells |
| US9376663B2 (en) | 2013-04-02 | 2016-06-28 | New York University | GPR15-mediated homing and uses thereof |
| US11850592B2 (en) | 2017-11-13 | 2023-12-26 | Owl biomedical, Inc. | Particle manipulation system with multisort valve |
| MX389160B (es) * | 2013-10-31 | 2025-03-20 | Hutchinson Fred Cancer Res | Células no t efectoras y madre/progenitoras hematopoyéticas modificadas y usos de estas. |
| US20170073406A1 (en) | 2014-05-06 | 2017-03-16 | Scholar Rock, Inc. | Compositions and methods for growth factor modulation |
| CA3197849A1 (en) | 2014-12-29 | 2016-07-07 | Novartis Ag | Methods of making chimeric antigen receptor-expressing cells |
| MX2017011194A (es) | 2015-03-03 | 2018-04-10 | Kymab Ltd | Anticuerpos, usos y métodos. |
| JP7062290B2 (ja) | 2015-07-31 | 2022-05-06 | ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． | がんに対する免疫チェックポイント阻害剤との併用療法における造血幹細胞 |
| CN115137752A (zh) | 2015-08-25 | 2022-10-04 | Uab研究基金会 | 用于干细胞移植的方法 |
| KR102768442B1 (ko) | 2015-09-07 | 2025-02-17 | 인스티튜트 내셔날 드 라 싼테 에 드 라 리셰르셰 메디칼르 | CD8+CD45RClow TREGS의 신규한 아집단 및 이들의 용도 |
| CA3003923A1 (en) | 2015-11-05 | 2017-05-11 | Glycostem Therapeutics B.V. | Composition for use in immunotherapy |
| US20190032013A1 (en) | 2016-01-29 | 2019-01-31 | Tract Therapeutics, Inc. | Immune cell selection, expansion, and use |
| WO2017143219A2 (en) | 2016-02-18 | 2017-08-24 | Viera Bioscience, Inc. | Stimulation of therapeutic angiogenesis by t regulatory cells |
| IL261750B2 (en) | 2016-03-14 | 2024-07-01 | Millennium Pharm Inc | Method of preventing graft versus host disease |
| WO2018106610A1 (en) | 2016-12-05 | 2018-06-14 | The Regents Of The University Of California | Immunomagnetic bead-based method to enrich stem cells from whole hematopoietic tissue |
| SG11201908271WA (en) | 2017-03-14 | 2019-10-30 | Juno Therapeutics Inc | Methods for cryogenic storage |
| EP3595683A1 (en) | 2017-03-15 | 2020-01-22 | Orca Biosystems, Inc. | Compositions and methods for hematopoietic stem cell transplants |
| US11662343B2 (en) | 2017-04-07 | 2023-05-30 | The Council Of The Queensland Institute Of Medical Research | Cellular populations and uses thereof |
| EP3450981A1 (en) | 2017-08-28 | 2019-03-06 | Trizell GmbH | Btnl8 as a marker for tregs |
| DK3749334T3 (da) | 2018-02-08 | 2025-02-17 | Univ Leland Stanford Junior | Allogen hæmatopoietisk stamcelletransplantation |
| WO2019178106A1 (en) | 2018-03-12 | 2019-09-19 | Medeor Therapeutics, Inc. | Methods for treating non-cancerous disorders using hematopoietic cells |
| US10842821B2 (en) | 2018-04-05 | 2020-11-24 | Medeor Therapeutics, Inc. | Cellular compositions derived from prior organ donors and methods of manufacture and use thereof |
| US10881692B2 (en) | 2018-04-05 | 2021-01-05 | Medeor Therapeutics, Inc. | Compositions for establishing mixed chimerism and methods of manufacture thereof |
| WO2020247341A1 (en) | 2019-06-06 | 2020-12-10 | Medeor Therapeutics, Inc. | Methods of making cellular products by post-mortem mobilization and harvesting of hematopoietic cells |
| WO2022098926A1 (en) | 2020-11-04 | 2022-05-12 | Orca Biosystems, Inc. | Methods for allogeneic hematopoietic stem cell transplantation |
-
2019
- 2019-02-07 DK DK19750722.1T patent/DK3749334T3/da active
- 2019-02-07 WO PCT/US2019/017017 patent/WO2019157158A2/en not_active Ceased
- 2019-02-07 US US16/967,375 patent/US11952588B2/en active Active
- 2019-02-07 PL PL19750722.1T patent/PL3749334T3/pl unknown
- 2019-02-07 AU AU2019218792A patent/AU2019218792A1/en not_active Abandoned
- 2019-02-07 JP JP2020542611A patent/JP7422667B2/ja active Active
- 2019-02-07 ES ES19750722T patent/ES3012854T3/es active Active
- 2019-02-07 CN CN201980024106.6A patent/CN111971052B/zh active Active
- 2019-02-07 EP EP24218671.6A patent/EP4529957A3/en active Pending
- 2019-02-07 CA CA3090175A patent/CA3090175A1/en active Pending
- 2019-02-07 EP EP19750722.1A patent/EP3749334B1/en active Active
-
2020
- 2020-09-24 US US17/031,187 patent/US20210002613A1/en not_active Abandoned
- 2020-09-24 US US17/031,213 patent/US11447747B2/en active Active
-
2022
- 2022-08-12 US US17/819,463 patent/US20220380729A1/en active Pending
-
2024
- 2024-01-16 JP JP2024004747A patent/JP7652949B2/ja active Active
- 2024-02-26 US US18/587,729 patent/US20240344027A1/en active Pending
-
2025
- 2025-11-19 AU AU2025271013A patent/AU2025271013A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021512903A5 (https=) | ||
| Chang et al. | Strategies for enhancing and preserving anti-leukemia effects without aggravating graft-versus-host disease | |
| US6544787B1 (en) | Non-myeloablative/lymphoablative conditioning regimen to induce patient anti-donor unresponsiveness in stem cell transplantation | |
| Saparov et al. | Preconditioning of human mesenchymal stem cells to enhance their regulation of the immune response | |
| Pérez-Martínez et al. | A phase I/II trial of interleukin-15–stimulated natural killer cell infusion after haplo-identical stem cell transplantation for pediatric refractory solid tumors | |
| Park et al. | Human umbilical cord blood cell grafts for brain ischemia | |
| Gómez-Almaguer et al. | Reduced-intensity stem cell transplantation in children and adolescents: the Mexican experience | |
| Kindwall-Keller et al. | Umbilical cord blood: The promise and the uncertainty | |
| CN107208061A (zh) | γδ T细胞扩增方法 | |
| Bader et al. | Rapid immune recovery and low TRM in haploidentical stem cell transplantation in children and adolescence using CD3/CD19-depleted stem cells | |
| JPWO2019157158A5 (https=) | ||
| Gismondi et al. | Effector functions of natural killer cell subsets in the control of hematological malignancies | |
| Abraham et al. | Cellular therapy for sickle cell disease | |
| Couban et al. | The case for plerixafor to replace filgrastim as the optimal agent to mobilize peripheral blood donors for allogeneic hematopoietic cell transplantation | |
| Locatelli et al. | Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation | |
| Ukrainskaya et al. | Haploidentical donor-derived memory CAR T cells: first in human experience and in vitro correlative study | |
| US20150374755A1 (en) | Treated Cells and Therapeutic Uses | |
| US20200306302A1 (en) | Treating and inhibiting leukemia with nk-92 cells | |
| EP3217975B1 (de) | Verwendung von immunmodulatorisch wirksamen zusammensetzungen zur immuntherapeutischen behandlung von patienten mit myeloischen leukämien | |
| Kondo et al. | Guidelines on cell therapy | |
| JP6401445B2 (ja) | 造血幹細胞移植用の組合せ細胞製剤および生着促進剤並びにこれらの製造方法 | |
| Lázár et al. | Difficulties of Mobilization and Harvesting of Hematopoietic Stem Cells in Heavily Pre-Treated Patients | |
| Zavala et al. | The Role of Hematopoietic Progenitors in Immune Regulation and Memory | |
| Kawamoto et al. | Design of a potentially registrational study of sakigake-designated GCSF-Mobilized autologous CD34 cell (CLBS12) Therapy of no-option critical limb ischemia including arteriosclerosis obliterans and Buerger's Disease | |
| Rejeski et al. | Hazal Aslan Rejeski1, 2, Anne Hartz1, 2, Elias Rackl1, 2, Lin Li1, 2, Christoph Schwepcke1, 2, Kai Rejeski1, 2, Christoph Schmid3, 4, Andreas Rank2, 3, Jörg Schmohl4, Doris Kraemer5, Peter Bojko6 and Helga Maria Schmetzer1, 2 |